Overview
RMD market data
Price History
RMD price chart · 1M
- O
- 229.96
- H
- 234.02
- L
- 229.27
- C
- 231.49
- Vol
- 49,413.00
- Source
- US equities market feed
- Observed
- Aug 21, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $229.96
- Previous Close
- $228.70
- Day High
- $234.02
- Day Low
- $229.27
- 52 Week High
- $259.45
- 52 Week Low
- $180.06
- 7 Day Return
- +3.48%
- 30 Day Return
- +20.20%
- 90 Day Return
- +11.61%
- 1 Year Return
- -10.11%
- Daily Notional Volume
- $11.4M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 21.47 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $10.43 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.74 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.2% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 26.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $180.27 – $293.81 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $32.7B · P/B 4.29 · P/S 5.79.
Company News
ResMed shares are trading higher after Rothschild & Co. initiated coverage on the stock with a Neutral rating and announced a $230 price target.Benzinga · Aug 19, 2026, 5:45 PM
Rothschild & Co Initiates Coverage On ResMed with Neutral Rating, Announces Price Target of $230Benzinga · Aug 19, 2026, 2:47 PM
RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $244Benzinga · Aug 7, 2026, 8:11 PM
ResMed shares are trading lower after multiple analyst firms lowered their respective price targets on the stock.Benzinga · Aug 7, 2026, 6:18 PM
JS&P 500 Hits Record As Jobs Shock Sinks Rate-Hike Bets: Stock Market TodayBenzinga · Aug 7, 2026, 5:27 PM
Piper Sandler Maintains Neutral on ResMed, Lowers Price Target to $225Benzinga · Aug 7, 2026, 5:08 PM
Keybanc Maintains Overweight on ResMed, Lowers Price Target to $255Benzinga · Aug 7, 2026, 2:13 PM
Wells Fargo Maintains Equal-Weight on ResMed, Lowers Price Target to $215Benzinga · Aug 7, 2026, 2:11 PM
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market SessionBenzinga · Aug 7, 2026, 12:02 PM
Resmed Raises Quarterly Dividend From $0.60 To $0.66/ShareBenzinga · Aug 6, 2026, 8:47 PM